TW253838B - - Google Patents

Info

Publication number
TW253838B
TW253838B TW082107450A TW82107450A TW253838B TW 253838 B TW253838 B TW 253838B TW 082107450 A TW082107450 A TW 082107450A TW 82107450 A TW82107450 A TW 82107450A TW 253838 B TW253838 B TW 253838B
Authority
TW
Taiwan
Application number
TW082107450A
Other languages
Chinese (zh)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW253838B publication Critical patent/TW253838B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW082107450A 1992-10-02 1993-09-10 TW253838B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95596292A 1992-10-02 1992-10-02

Publications (1)

Publication Number Publication Date
TW253838B true TW253838B (no) 1995-08-11

Family

ID=25497602

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082107450A TW253838B (no) 1992-10-02 1993-09-10

Country Status (12)

Country Link
EP (1) EP0662826A1 (no)
JP (1) JPH07507565A (no)
KR (1) KR950703333A (no)
AU (1) AU5095393A (no)
CA (1) CA2145763A1 (no)
FI (1) FI934317A (no)
HU (1) HUT69400A (no)
IL (1) IL107084A0 (no)
MX (1) MX9306125A (no)
TW (1) TW253838B (no)
WO (1) WO1994007472A1 (no)
ZA (1) ZA937268B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
SE9602145D0 (sv) 1996-05-31 1996-05-31 Astra Ab New improved formulation for treatment of thromboembolism
KR101390695B1 (ko) * 2006-08-01 2014-04-30 오츠카 세이야쿠 가부시키가이샤 약리 활성 물질의 흡수성이 개선된 의약 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS6233128A (ja) * 1985-08-07 1987-02-13 Toray Ind Inc インタ−フエロン腸溶性経口用製剤
ATE94404T1 (de) * 1988-07-21 1993-10-15 Hoffmann La Roche Insulinzubereitung.
AU1256692A (en) * 1991-02-06 1992-09-07 Schering Corporation Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor
AU3058392A (en) * 1991-12-18 1993-07-19 Pfizer Inc. Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation

Also Published As

Publication number Publication date
AU5095393A (en) 1994-04-26
MX9306125A (es) 1994-04-29
KR950703333A (ko) 1995-09-20
FI934317A0 (fi) 1993-10-01
HU9302774D0 (en) 1993-12-28
WO1994007472A1 (en) 1994-04-14
JPH07507565A (ja) 1995-08-24
CA2145763A1 (en) 1994-04-14
IL107084A0 (en) 1993-12-28
HUT69400A (en) 1995-09-28
EP0662826A1 (en) 1995-07-19
ZA937268B (en) 1995-03-30
FI934317A (fi) 1994-04-03

Similar Documents

Publication Publication Date Title
DK0634000T3 (no)
TW243557B (no)
DK0652790T3 (no)
TW222251B (no)
TW222654B (no)
TW233343B (no)
TW234785B (no)
DK0599160T3 (no)
DK0596750T3 (no)
DK0644844T3 (no)
DK0632741T3 (no)
DK0554977T3 (no)
DK114493A (no)
DK0576346T3 (no)
TW224507B (no)
DK0574276T3 (no)
DK0564197T3 (no)
DK113692D0 (no)
DK0596569T3 (no)
TW253838B (no)
DK0597323T3 (no)
DK0559942T3 (no)
TW237535B (no)
DK145992D0 (no)
IN177333B (no)